✦ LIBER ✦

A phase II study of alternating dose-dense chemotherapy in patients with poor-prognosis disseminated non-seminomatous germ cell tumors (NSGCT): Final results

✍ Scribed by Karim Fizazi; Kim-Anh Do; Xuemei Wang; Debrah M. Prow; Laury Finn; Christopher J. Logothetis; Robert J. Amato

Book ID: 117658673
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 172 KB
Volume: 37
Category: Article
ISSN: 0959-8049
DOI: 10.1016/s0959-8049(01)81312-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of salvage dose-dense che

Phase II study of salvage dose-dense chemotherapy in patients with disseminated non-seminomatous germ cell tumors (NSGCT): Final results

✍ K. Fizazi; Kim-Anh Do; Xuemei Wang; Debrah M. Prow; Laury Finn; Christopher J. L 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 169 KB

Alternating dose-dense chemotherapy in p

Alternating dose-dense chemotherapy in patients with high volume disseminated non-seminomatous germ cell tumours

✍ Fizazi, K; Prow, D M; Do, K-A; Wang, X; Finn, L; Kim, J; Daliani, D; Papandreou, 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 96 KB

Paclitaxel + BEP (T-BEP) Regimen as Indu

Paclitaxel + BEP (T-BEP) Regimen as Induction Chemotherapy in Poor Prognosis Patients With Nonseminomatous Germ Cell Tumors: A Phase II Study

✍ A. Tryakin; M. Fedyanin; D. Kanagavel; I. Fainstein; J. Sergeev; B. Polockij; V. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 305 KB

Paclitaxel + BEP (T-BEP) Regimen as Indu

Paclitaxel + BEP (T-BEP) Regimen as Induction Chemotherapy in Poor Prognosis Patients With Nonseminomatous Germ Cell Tumors: A Phase II Study

✍ A. Tryakin; M. Fedyanin; D. Kanagavel; I. Fainstein; J. Sergeev; B. Polockij; V. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 305 KB

## Objectives: To evaluate paclitaxel, bleomycin, etoposide, and cisplatin (t-bep) in patients with poor-prognosis nonseminomatous germ cell tumor (nsgct). paclitaxel is an active treatment of nonseminomatous germ cell tumors. ## Methods: The present study was an open-label, single-center, phase

RANDOMISED PHASE III TRIAL COMPARING RET

RANDOMISED PHASE III TRIAL COMPARING RETROPERITONEAL LYMPH NODE DISSECTION (RPLND) WITH ONE COURSE OF BLEOMYCIN, ETOPOSIDE, CISPLATIN (BEP) CHEMOTHERAPY IN PATIENTS WITH STAGE I NON-SEMINOMATOUS GERM CELL TUMOUR PATIENTS (NSGCT) – UPDATED RESULTS OF AUO TRIAL 01/94

✍ P. Albers; R. Siener; S. Krege; H.U. Schmelz; K.P. Dieckmann; A. Heidenreich; P. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 69 KB

139 Alternant chemotherapy (CT) with cis

139 Alternant chemotherapy (CT) with cisplatin, iphosphamide and mitomycin, vinorelbine in the treatment of non small cell lung cancer (NSCLC). Final results of a phase II cooperative study

✍ Rinaldi, M.; Noseda, M.A.; Lopez, M.; Cipri, A.; Spadoni, M.; Moreschi, M.; Gare 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 154 KB